INCY Incyte Earnings and EPS analysis

EPS in 2025 (TTM): $0.29

Last Report Period Date: Mar 31, 2025

As of July this year, based on Incyte's latest financial report, the company's current EPS (TTM) is $0.29. In 2024, INCY reported a per-share earnings of $0.16, which represents a decrease compared to the EPS of $2.67 recorded in 2023. Incyte's EPS for the quarterly period ending on Mar 31, 2025 was $0.82.

INCY earnings history

Historical annual and quarterly earnings per share (EPS) data for Incyte
EPS (TTM)
$0.29
EPS Growth YoY (Quarterly)
7.9%
EPS (Quarterly)
$0.82
EPS Growth (Quarterly)
-14.6%

The yearly EPS in 2024 was $0.16, a decrease of 94% compared to $2.67 recorded in 2023. For the quarter ending Mar 31, 2025, the EPS was $0.82, reflecting a 7.9% increase compared to the same quarter a year earlier. The trailing twelve months (TTM) EPS as of March 2025 is $0.29. In 2023, the annual EPS was $2.67, showing an increase of 74.5% compared to 2022.

INCY EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
7.9%
EPS growth YoY
-94%
EPS growth 3Y avg
-66.6%
EPS growth 5Y avg
-40.1%

Incyte has recorded a growth in earnings per share of 7.9% over the past 12 months (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS annual growth rate of -66.6% per year for the last 3 years. Incyte had an average annual EPS growth of -40.1% over the last five years.

INCY Earnings Waterfall

Breakdown of revenue, profit and net income for Incyte

INCY Earnings vs Peers

What are the earnings of INCY compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
NVS Novartis AG 17.03 -17.2% -17.9% 2.9%
PFE Pfizer Inc 17.83 273.7% -28.7% -13.2%
AMGN Amgen Inc 27.74 -39.3% -9.7% -10.1%
LLY ELI LILLY & Co 65.86 102.1% 24.1% 5.7%
INCY Incyte Corp 242.07 -94% -66.6% -40.1%
LGND Ligand Pharmaceuticals Inc N/A -107.3% N/A N/A
ARDX Ardelyx Inc N/A 43.3% N/A N/A
GERN Geron Corp N/A 15.6% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.